Neural correlates of cognitive motor interference (CMI) while walking

ISRCTN ISRCTN59902842
DOI https://doi.org/10.1186/ISRCTN59902842
Secondary identifying numbers TSA 2007/09
Submission date
17/11/2008
Registration date
27/11/2008
Last edited
06/06/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Helen Dawes
Scientific

School of Life Sciences
Oxford Brookes University
Oxford
OX3 0BP
United Kingdom

Study information

Study designObservational cross-sectional study
Primary study designObservational
Secondary study designCross sectional study
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleCortical activation of cognitive motor interference while walking: a near-infrared spectroscopic study
Study acronymCMI
Study objectives1. There may be a relationship between the degree of regional brain activation and/or the temporal activation pattern and performance in cognitive and motor tasks under dual task conditions
2. This relationship may be different following a stroke than in healthy controls
Ethics approval(s)Oxfordshire Research Ethics Committee C, 24/07/2008, ref: 08/H0606/55
Health condition(s) or problem(s) studiedStroke
InterventionBaseline assessments include:
1. The Mini Mental State Examination: the MMSE is a brief screening tool to provide quantitative assessment of cognitive function. It consists of 11 simple questions or tasks. Typically, they are grouped into seven domains; orientation to time, orientation to place, registration of three words, attention and calculation.
2. Edinburgh Handedness Inventory: this is a brief questionnaire of 10 short items, which determines subject's hand dominance.
3. Barthel Index: a simple index of independence in activities of daily living (ADL). It consists of 10 common ADL activities, which they are assessed for independence/dependence.
4. Modified Physical Activity Scale for the elderly: a self reported physical activity questionnaire that covers one week.
5. Berg Balance Scale (BBS): the BBS provides a quantitative assessment of balance. It consists of 14 items requiring subjects to maintain or complete movement tasks of varying levels of difficulty. All items are common to everyday life.

The results of the assessments above will be reported together with the primary/secondary outcomes, as they might correlate with differences in CMI.

Brain activation in both stroke and control subjects will be examined by near-infrared spectroscopy (NIRS) alongside behavioural performance of walking and cognitive tasks (calculation). The participants will be asked to perform the concurrent tasks when seated and walking. Gait parameters will be measured using a well-validated gait analysis system (Xsens, The Netherlands).
Intervention typeOther
Primary outcome measureTask-related changes in oxygenated and deoxygenated haemoglobins in the frontal lobe as measured by NIRS.
Secondary outcome measures1. Rate of backward calculation (number per minute)
2. Number of errors in backward calculation (errors per trial)
3. Spatiotemporal gait measures (speed, cadence, step time, stride time, step length, stride length, step width)
Overall study start date01/07/2008
Completion date01/07/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants36
Key inclusion criteriaPatients will be selected from those treated in the Oxford Radcliffe Hospitals who are:
1. More than 6 months following a first stroke
2. Both males and females, aged 45 to 80 years
3. With an ischaemic infarct upon computed tomography (CT) or magnetic resonance imaging (MRI) scan
3. Able to perform a simple reciprocal bilateral foot tapping task, walk safely on a treadmill with or without mobility aids
4. Be able to give informed consent

Sex and age-matched controls will be chosen who do not have a known neurological disease, a history of hypertension, cardiac disease or diabetes.
Key exclusion criteria1. Dementia
2. Aphasia significantly limiting communication
3. History of previous symptomatic strokes or neurological disease
4. Known psychiatric disease or claustrophobia, or other conditions precluding safe MRI (e.g., pacemaker or other metal implant)
Date of first enrolment01/07/2008
Date of final enrolment01/07/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Oxford Brookes University
Oxford
OX3 0BP
United Kingdom

Sponsor information

Oxford Brookes University (UK)
University/education

c/o Prof Linda King
School of Life Sciences
Oxford
OX3 0BP
England
United Kingdom

Website http://www.brookes.ac.uk
ROR logo "ROR" https://ror.org/04v2twj65

Funders

Funder type

Charity

Stroke Association (ref: TSA 2007/09)
Private sector organisation / Associations and societies (private and public)
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

06/06/2016: No publications found, verifying study status with principal investigator.